30 Actinic Keratosis (Solar Keratosis)

Size: px
Start display at page:

Download "30 Actinic Keratosis (Solar Keratosis)"

Transcription

1 30 Actinic Keratosis (Solar Keratosis) CLINICAL APPLICATION QUESTIONS A 65-year-old white man is seen at your office for multiple scaling lesions over his face, ears, neck, and the V of the chest. These have developed gradually over several years. He is an outdoor sportsman. He is concerned about the character and potential of these lesions, and would like to have them removed because they are itchy and irritable. Physical examination of the involved regions reveals multiple actinic keratoses (AKs). Careful examination reveals no lesions that appear overtly malignant. 1. What are the primary lesions that you would expect to find in actinic keratoses? 2. What are the secondary lesions that you would expect to find in actinic keratoses? 3. What should you tell the patient about actinic keratoses? 4. How should you treat actinic keratoses in this patient? APPLICATION GUIDELINES Specific History Onset This type of keratosis is seen with increased incidence in patients from the fifth decade of life onward. The individual lesions begin insidiously as erythematous patches of vasodilation that are often more apparent after solar exposure. Early lesions are usually otherwise asymptomatic. Evolution of Disease Process AKs develop after a long latency period (one to two decades), and are caused primarily by solar radiation in the UVB or sunburn range from 2900 to 3200 Å. They occur in groupings and are limited to sun-exposed skin. The early erythematous lesions can progress to forms that (1) scale (keratotic type), (2) thicken dramatically (cutaneous horn type), (3) develop a brown branny scale (pigmented type), or (4) become violaceous, slightly indurated, and inflamed to resemble papules of lichen planus (lichenoid type). The last type is uncommon and probably represents an AK with an immune response aimed at rejection. These more developed forms are often mildly symptomatic and patients will complain of intermittent itching and prickling, especially after solar exposure. Following a lengthy latent period some AKs evolve into squamous cell carcinomas, usually of low metastatic potential. Patients will occasionally report spontaneous clearing of specific lesions, possibly a consequence of the histologic changes seen in the lichenoid type. From: Current Clinical Practice: Dermatology Skills for Primary Care: An Illustrated Guide D.J. Trozak, D.J. Tennenhouse, and J.J. Russell Humana Press, Totowa, NJ 287

2 288 Part V / Malignant Skin Diseases Thickening at the base of an AK, the presence of a cutaneous horn, or failure to respond promptly to proper cryotherapy should suggest the possibility of malignancy. Evolution of Skin Lesions See Evolution of Disease Process section, above. Provoking Factors Extensive sun exposure obtained during recreation or in outdoor occupations is the major cause. Climates with predominantly warm sunny days, increased proximity to the equator, and exposure at higher altitudes all increase the injury, which is of a cumulative nature. These lesions occur primarily in persons of Celtic heritage with types I and II complexions, who sunburn easily. Self-Medication Inappropriate self-treatment with topical 5-fluorouracil (5-Fu) obtained from relatives or prescribed by misguided practitioners can alter lesions or hide established malignancies without effectively removing them. Patients will also attempt to treat themselves with various cosmetics and patent medications, but soon discover that this is fruitless. Supplemental Review From General History A history of lifetime sun exposure, ease of burning, and regular use of sunscreens and protective clothing should be reviewed. Dermatologic Physical Exam Primary Lesions 1. Erythematous macules and patches 0.5 to 1 cm across (see Photo 36). 2. Thin plaques 0.5 to 1 cm across with secondary changes (see Photo 37). Secondary Lesions 1. Adherent white, yellow, or brown scale that is removed with difficulty, and upon removal may leave a depressed bleeding base (see Photos 36 39). 2. A cutaneous horn that is firmly attached and may extend a centimeter or more above the normal skin surface (see Photo 38). 3. Erosions (see Photo 39). 4. Ulcerations (see Photo 39). An indurated base, cutaneous horn, or the presence of erosions or ulceration should raise the possibility of malignant transformation within an AK. If a lesion of this type is treated without biopsy, it should be followed up within 4 to 6 weeks to be certain there has been a complete response. Distribution Microdistribution: Follicular: AKs will occasionally occur at the ostium of a hair follicle. Follicular AKs are most often seen on the upper facial area and nose. Because the cellular changes extend down the follicular infundibulum, they usually recur after cryotherapy.

3 Chapter 30 / Actinic Keratosis 289 Figure 8: Macrodistribution of actinic keratosis. Macrodistribution: AKs are distributed on sun-exposed skin such as the upper face, malar and zygomatic eminences, ears, dorsal forearms, and the V area of the upper chest (see Fig. 8). Configuration Configuration is grouped. Indicated Supporting Diagnostic Data Biopsy The vast majority of AKs can be diagnosed and treated based on clinical examination. When there is a question about intervening malignancy, a punch biopsy should distinguish them.

4 290 Part V / Malignant Skin Diseases Therapy Cryosurgery Light applications of liquid nitrogen (LN 2 ) sufficient to produce a 0.5- to 1-mm rim of freeze at the perimeter of the base of the AK are usually satisfactory for total removal. The advantage of this technique is the absence of scarring. Persons with olive complexions must be warned about the possibility of posttreatment hyper- or hypopigmentation. During the sunny season, warn patients about sun exposure and the use of a sunscreen with makeup to prevent posttreatment darkening, and for future prevention. Cryosurgery is the technique of choice in patients with a small number of lesions or in patients who cannot comply with, or who refuse, topical therapy. Patients should be warned to return if any lesion fails to resolve within 4 to 6 weeks. Topical Chemotherapy The advantage of topical chemotherapy is the ability to destroy actinic damage that is otherwise invisible and would be missed with cryotherapy. Patients with large numbers of keratoses or a great deal of latent injury, who are reliable and will follow through, are ideal candidates. Topical chemotherapy should be started only after the intended treatment sites have been examined for overtly malignant lesions. This therapy can remove the surface signs of an established cancer while it continues to spread beneath the epidermal surface. 5-fluorouracil: 5-FU selectively seeks out and destroys AKs with little or no effect on the adjacent normal skin. This medication is available as a 0.5% cream with time-releasing microsponges incorporated into the vehicle. It is also marketed as a 1% water-washable cream and as 2% and 5% solutions in propylene glycol. All of the products work in a similar fashion and have excellent efficacy. The 0.5% cream has the advantage of a single daily application, which improves patient compliance. Patients are instructed to apply the agent to the affected area in a thin layer morning and evening or once daily, depending on the preparation chosen. Careful instructions are needed or the reaction may be very disconcerting to the patient. Within 5 to 6 days, selected areas of damage and visible keratoses will become red, itchy, angry, and irritable. Different patients show different tolerance, and fair-skinned persons seem more reactive. Lesions should be treated until they are inflamed and some of the thinner lesions are coming off. Some lesions may erode and bleed, and patients will need reassurance that this is not a complication. After this point is reached, the treatment is stopped and patients are switched to a low-potency steroid preparation such as topical 0.05% desonide in a soothing lubricating cream base. This product should be used morning and evening until the redness and irritation has resolved; then it should be discontinued. Follow patients up 6 weeks from the time the 5-FU is stopped. At that time, there are usually scattered thick lesions that have not responded, and these are removed with LN 2. During 5-FU treatment, patients should be warned to minimize solar exposure. Significant sun can rapidly accelerate the reaction, and although no permanent injury will result, the effect is frightening and uncomfortable. A second method of using 5-FU is the treat through technique. The drug is continued until the reaction ceases as the AKs are eliminated. Few patients will put up with this duration of irritation, and occasional patients who show nonspecific irritation to 5-FU would not fare well with this technique.

5 Chapter 30 / Actinic Keratosis 291 A third method is to use 5-FU and a topical steroid together over a longer period of time. The intent is to reduce irritation and increase compliance. Although reported effective, there is no substantial body of evidence to show that this method has equivalent efficacy. Diclofenac sodium: This medication is prepared as a 3% gel and is applied twice daily to the affected sun-damaged areas morning and evening. Treatment is recommended for 60 to 90 days, and patients should then have a follow up visit at 6 weeks to freeze any lesions that have not responded. During therapy patients should be warned to minimize sun exposure. This medication is a safe alternative for patients allergic to 5-FU. Head-tohead comparisons with long-term follow-up between the two agents has not been reported. The prolonged treatment course raises questions regarding patient compliance. Despite claims to the contrary, patients do experience erythema and irritation with diclofenac sodium similar to that seen with 5-FU. Imiquimod: Imiquimod cream 5%, an immune modulator that has been available for several years for treatment of genital and perianal warts, is also approved for the treatment of actinic keratosis. Like topical 5-FU, it selectivley destroys malignant keratinocytes but leaves normal ones alone. It is applied twice weekly for a period of 16 weeks. Applications are done at bedtime and left on for 8 hours. Efficacy appears excellent, with 75% or greater reduction of lesions. Drawbacks to this treatment are the prolonged treatment time, which would diminish compliance, and the current cost, which is five or six times the cost of other products. Curettage and Electrodesiccation Removal by this technique should be undertaken only with the rare lesions that fail to respond to topical or cryotherapy. Although effective, this method of destruction leaves superficial scarring, which is seldom justified. The patient should be forewarned. Prevention Solar avoidance and covering up with adequate clothing prevents these premalignant lesions. In female patients, the daily use of makeup that contains or is used over a sunscreen provides substantial protection from keratosis and from the chronic aging effects of the sun. High SPF sunscreen (30 or greater), (preferably containing Parsol), used on a daily basis has been shown to substantially reduce their occurrence. Conditions That May Simulate Actinic Keratosis Seborrheic Keratosis (SKs) Pigmented AKs can appear quite similar to early SKs. Actinic lesions are thin and do not show a defined edge or the stuck-on appearance of the seborrheic type. In addition, AKs show telangectasia and an adherent scale that often leaves bleeding points when removed. Solar Lentigo Pigmented AKs can also be confused with solar lentigines. The latter lesion is usually macular with normal skin markings, whereas the actinic lesion has a scale, and the surface markings are lost.

6 292 Part V / Malignant Skin Diseases Discoid Lupus Erythematosus (DLE) Large AKs can be confused with plaques of DLE because of the telangectasia, adherent white scale, and solar distribution. AKs have a more adherent scale, are usually grouped, and do not show the scarring seen with DLE. The scale of DLE, when removed, shows carpet-tacking (see Chapter 19). Squamous Cell Carcinoma Differentiation from this malignant tumor is discussed in the chapter on squamous cell carcinoma. ANSWERS TO CLINICAL APPLICATION QUESTIONS History Review A 65-year-old white man is seen at your office for multiple scaling lesions over his face, ears, neck, and the V of the chest. These have developed gradually over several years. He is an outdoor sportsman. He is concerned about the character and potential of these lesions, and would like to have them removed because they are itchy and irritable. Physical examination of the involved regions reveals multiple actinic keratoses. Careful examination reveals no lesions that appear overtly malignant. 1. What are the primary lesions that you would expect to find in actinic keratoses? Answer: Erythematous macules, patches, and thin plaques 5 to 10 mm in size. 2. What are the secondary lesions that you would expect to find in actinic keratoses? Answer: a. Adherent white, yellow, or brown scale. b. Erosions. c. Ulcerations. 3. What should you tell the patient about actinic keratoses? Answer: Actinic keratoses are the result of chronic sun exposure and are precancerous lesions. Over a period of time, some of them may change into skin cancers. Removal is recommended because of their malignant potential. 4. How should you treat actinic keratoses in this patient? Answer: This patient may be treated with topical chemotherapy. Because he has large numbers of lesions, this approach is cost-effective. Cryosurgery is appropriate for patients with a small number of actinic keratoses, for patients who cannot comply with a topical chemotherapy regimen, or for patients who simply refuse topical chemotherapy. Cryosurgery is also indicated for the removal of any lesions that do not respond to topical chemotherapy. Topical agents are of marginal value for thick actinic keratoses on the dorsum of the hands and forearms. Cryotherapy is more cost-effective in these locations.

BL-5010P A NOVEL PRE-FILLED APPLICATOR FOR THE NON-SURGICAL REMOVAL OF SKIN LESIONS

BL-5010P A NOVEL PRE-FILLED APPLICATOR FOR THE NON-SURGICAL REMOVAL OF SKIN LESIONS BL-5010P A NOVEL PRE-FILLED APPLICATOR FOR THE NON-SURGICAL REMOVAL OF SKIN LESIONS 25 Skin lesions Miri Seiberg, PhD 26 Skin lesions A part of the skin that has an abnormal growth or appearance compared

More information

Clinical characteristics

Clinical characteristics Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic

More information

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating Learning Objectives Skin Cancers: Preventing, Screening and Treating Robert A. Baldor, MD, FAAFP Professor, Family Medicine & Community Health University of Massachusetts Medical School Distinguish the

More information

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk. Basics of Skin Cancer Detection and Treatment of Non- Melanoma Skin Cancers Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest

More information

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc 1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late

More information

Richard Turner Consultant Dermatologist

Richard Turner Consultant Dermatologist Old Problems & New Treatments Photo Album by Administrator Richard Turner Consultant Dermatologist Plan for tonight? Refresher on SCC and solar keratosis How to distinguish the two Classic therapy than

More information

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D. Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma

More information

Living Beyond Cancer Skin Cancer Detection and Prevention

Living Beyond Cancer Skin Cancer Detection and Prevention Living Beyond Cancer Skin Cancer Detection and Prevention Cutaneous Skin Cancers Identification Diagnosis Treatment options Prevention What is the most common cancer in people? What is the most common

More information

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated Lindy P. Fox, MD Assistant Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant

More information

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses. Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.

More information

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine Glenn D. Goldman, MD University of Vermont Medical Center University of Vermont College of Medicine Recognize and identify the main types of skin cancer and their precursors Identify and understand new

More information

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something

More information

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry Skin lesions The Good and the Bad Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry Case 1 32 year old woman Australian Lesion on back New hair growing

More information

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant

More information

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI

More information

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine Glenn D. Goldman, MD Fletcher Allen Health Care University of Vermont College of Medicine Recognize and identify the main types of skin cancer Understand how and why Mohs surgery is utilized for the treatment

More information

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Case Presentation 57 yo man with 3 month hx of a nonhealing < 1 cm right

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium imiquimod 5% cream (Aldara) No. (385/07) Meda Pharmaceuticals Ltd 04 April 2008 The Scottish Medicines Consortium has completed its assessment of the above product and advises

More information

Skin Cancer - Non-Melanoma

Skin Cancer - Non-Melanoma Skin Cancer - Non-Melanoma Introduction Each year, millions of people find out that they have skin cancer. Skin cancer is almost 100% curable if found early and treated right away. It is possible to prevent

More information

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma

More information

Actinic keratosis (AK): Dr Sarma s simple guide

Actinic keratosis (AK): Dr Sarma s simple guide Actinic keratosis (AK): Dr Sarma s simple guide Actinic keratosis is a very common lesion that you will see in your day-to-day practice. First, let me explain the name Actinic keratosis. It means keratosis

More information

Periocular skin cancer

Periocular skin cancer Periocular skin cancer Information for patients Skin cancer involving the skin of the eyelid or around the eye is called a periocular skin cancer. Eyelid skin cancers occur most often on the lower eyelid,

More information

Periocular Malignancies

Periocular Malignancies Periocular Malignancies Andrew Gurwood, O.D., F.A.A.O., Dipl. Marc Myers, O.D., F.A.A.O. Drs. Myers and Gurwood have no financial interests to disclose. Course Description Discussion of the most common

More information

Have a Voice in Your Choice!

Have a Voice in Your Choice! Have a Voice in Your Choice! BLU-U Blue Light Photodynamic Therapy The LEVULAN KERASTICK for Topical Solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is

More information

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1 Skin Cancer AMERICAN OSTEOPATHIC COLLEGE OF OCCUPATIONAL & PREVENTIVE MEDICINE OMED 2012 October 8, 2012 E. Robert Wanat II, D.O., M.P.H. Learning Objectives: Identify the 3 Basic Types of Skin Cancer

More information

General information about skin cancer

General information about skin cancer Skin Cancer General information about skin cancer Key points Skin cancer is a disease in which malignant (cancer) cells form in the tissues of the skin. There are different types of cancer that start in

More information

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT Tammy P. Than, M.S., O.D., F.A.A.O. The University of Alabama at Birmingham / School of Optometry 1716 University Blvd. Birmingham, AL

More information

Actinic Keratoses and Bowen s disease

Actinic Keratoses and Bowen s disease Actinic Keratoses and Bowen s disease Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW MOHS MICROGRAPHIC SURGERY: AN OVERVIEW SKIN CANCER: Skin cancer is far and away the most common malignant tumor found in humans. The most frequent types of skin cancer are basal cell carcinoma, squamous

More information

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,

More information

Disclosures. I have no conflicts of interest to disclose

Disclosures. I have no conflicts of interest to disclose Disclosures I have no conflicts of interest to disclose Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco 2

More information

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH Dermatological Manifestations in the Elderly Sanjay Siddha Staff Dermatologist UHN & MSH Disclosure No actual or potential conflicts of interest or commercial relationships to declare Objectives Recognize

More information

SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA SQUAMOUS CELL CARCINOMA What are the aims of this leaflet? This leaflet has been written to help you understand more about squamous cell carcinomas of the skin. It tells you what they are, what causes

More information

Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM

Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM Dilemmas and Challenges in Skin Cancer Therapies and Management Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM Roger I. Ceilley, M.D. Clinical Professor of Dermatology The University of Iowa

More information

Work Place Carcinogens Solar Radiation and Skin Cancer. November 2013 Dr Mark Foley

Work Place Carcinogens Solar Radiation and Skin Cancer. November 2013 Dr Mark Foley Work Place Carcinogens Solar Radiation and Skin Cancer November 2013 Dr Mark Foley Overview Work place carcinogens and skin cancer Who is a risk? Screening and Self skin exam Common skin cancers Many work

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate PACKAGE LEAFLET: INFORMATION FOR THE USER Flutarzole 0,05% w/w cream, Fluticasone propionate 1. IDENTIFICATION OF THE MEDICINAL PRODUCT 1.1. Trade name Flutarzole 1.2. Composition Active substance: Fluticasone

More information

Thursday 21 st August Skin Problems

Thursday 21 st August Skin Problems Thursday 21 st August 2014 Skin Problems Skin Problems The Sun and the Skin Sun Damage Recognising the early signs of skin cancer The Big 3 inflammatory condi=ons Acne & Rosacea Eczema (Including Seborrhoeic

More information

Topical Diclofenac Gel, Fluorouracil Cream, Imiquimod Cream, and Ingenol Gel Prior Authorization with Quantity Limit Program Summary

Topical Diclofenac Gel, Fluorouracil Cream, Imiquimod Cream, and Ingenol Gel Prior Authorization with Quantity Limit Program Summary Topical Diclofenac Gel, Fluorouracil Cream, Imiquimod Cream, and Ingenol Gel Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-8 Topical Diclofenac Gel Indication

More information

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with

More information

Case-Based Approach to Common Dermatologic Neoplasms

Case-Based Approach to Common Dermatologic Neoplasms Case-Based Approach to Common Dermatologic Neoplasms Patrick Retterbush, MD, FAAD Mohs Surgery & Dermatologic Oncology Associate Member of the American College of Mohs Surgery Private Practice: Lockman

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 5 PURPOSE To assure that DOP inmates with skin lesions are receiving appropriate Primary Care for their lesions POLICY All DOP Primary Care Providers are expected to follow this guideline and/or

More information

Premalignant skin tumours

Premalignant skin tumours Chapter 14: Premalignant skin tumours page: 434 Premalignant skin tumours page: 435 Solar keratoses (senile keratoses) Raised red and well-defined plaques with a rough surface covered in scales of varying

More information

fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A.

fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A. fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above

More information

Aldara. Aldara (imiquimod) Description

Aldara. Aldara (imiquimod) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.19 Subject: Aldara Page: 1 of 5 Last Review Date: March 17, 2017 Aldara Description Aldara (imiquimod)

More information

Dual Wavelength Phototherapy System

Dual Wavelength Phototherapy System Dual Wavelength Phototherapy System The AKLARUS Blue and Red Combination System is an effective, drugfree alternative for treating acne & photodamaged skin. The non-invasive Aklarus treatment has been

More information

ALL THINGS DERMATOLOGY

ALL THINGS DERMATOLOGY ALL THINGS DERMATOLOGY Dr Aravind Chandran Dermatologist Auckland District Health Board and Skin Specialist Centre Honorary Lecturer University of Auckland ALL THINGS DERMATOLOGY PITFALLS & PRACTICAL TIPS

More information

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer Skin Cancer 101: Diagnosis and Management of the Most Common Cancer Sarah Patton, PA-C, MSHS Skin Surgery Center www.skinsurgerycenter.com Seattle/Bellevue, WA Skin cancer Skin cancer is by far the most

More information

Warts. Dr. Ghassan Salah

Warts. Dr. Ghassan Salah Warts Dr. Ghassan Salah Background Information Warts are small harmless lesions of the skin caused by a virus: the human papilloma virus. The appearance of warts can differ based on the type of wart and

More information

Page 1 of 15 Title Authored By Course No Contact Hours 2 Skin Cancer the Real Picture for Early Detection and Treatment Cheryl Sommer RN, MSN, ARNP SC120604 Purpose The purpose of this course is to provide

More information

Lagophthalmos. Lagophthalmos: signs. Lagophthalmos: clinical tips. Lagophthalmos: treatment plan. Madarosis

Lagophthalmos. Lagophthalmos: signs. Lagophthalmos: clinical tips. Lagophthalmos: treatment plan. Madarosis Lagophthalmos Def: incomplete closure of the eyelid SX: FBS, irritation, red, burn, dry, chronic morning corneal irritation Lagophthalmos: signs 2-5 mm lid separation with slit lamp during blink can force

More information

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose Disclosures Melanoma and Non melanoma Skin Cancer: What You Need to Know I have no conflicts of interest to disclose Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department

More information

Oral and Maxillofacial Surgery Department

Oral and Maxillofacial Surgery Department Oral and Maxillofacial Surgery Department This leaflet explains: Lentigo Maligna What are the aims of this leaflet? This leaflet has been written to help you understand more about lentigo maligna and melanoma

More information

Diagnosis and Management of Actinic Keratosis (AKs)

Diagnosis and Management of Actinic Keratosis (AKs) Diagnosis and Management of Actinic Keratosis (AKs) Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada

More information

Basal cell carcinoma

Basal cell carcinoma Basal cell carcinoma Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm What are basal

More information

Skin Deep: Cutaneous Lupus. Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016

Skin Deep: Cutaneous Lupus. Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016 Skin Deep: Cutaneous Lupus Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016 Introduction: Cutaneous lupus erythematosus LE is an autoimmune disease with a range of clinical manifestations

More information

Case Presentation Protocol 2018 Hot Spots in Dermatology

Case Presentation Protocol 2018 Hot Spots in Dermatology Metastatic 1 Running Head: METASTATIC BASAL CELL CARCINOMA Case Presentation Protocol 2018 Hot Spots in Dermatology A Case Study of Metastatic BCC Marianna F. Karewicz, NP Mentor: Dr. Roman W. Glamb, MD

More information

Skin lesions & Abrasions

Skin lesions & Abrasions Skin lesions & Abrasions What Are Skin Lesions? A skin lesion is a part of the skin that has an abnormal growth or appearance compared to the skin around it Types of Skin Lesions Two types of skin lesions

More information

Case presentation. Dr Rammohan Reddy 1 st year PG, Dept of DVL, Kamineni Institute of Medical Sciences, Narketpally.

Case presentation. Dr Rammohan Reddy 1 st year PG, Dept of DVL, Kamineni Institute of Medical Sciences, Narketpally. Case presentation Dr Rammohan Reddy 1 st year PG, Dept of DVL, Kamineni Institute of Medical Sciences, Narketpally. Name : XXX Age : 33 years Sex : Female Occupation : Farmer IP no : 201608905 DOA : 15-02-2016

More information

Regeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018

Regeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018 A D E E P E R L O O K When detected early, most cases of local cutaneous squamous cell carcinoma are easily treated and usually cured. But when they become more advanced, this second most common form of

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 26 November 2008

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 26 November 2008 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 26 November 2008 ALDARA 5%, cream Box of 12 sachets of 250 mg (CIP: 349 204-4) Applicant: MEDA PHARMA imiquimod ATC

More information

APOC-5FU Cream Fluorouracil

APOC-5FU Cream Fluorouracil APOC-5FU Cream Fluorouracil Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet This leaflet answers some common questions about APOC-5FU. It does

More information

NEHSNORTH EASTERN HEALTH SPECIALISTS

NEHSNORTH EASTERN HEALTH SPECIALISTS COSMETIC DERMATOLOGY NEHSNORTH EASTERN HEALTH SPECIALISTS nehs.com.au CONSENT FORM VASCULAR Treatment with BBL & LASERS I, DOB:, of authorize of North Eastern Health Specialist to perform hair removal

More information

Treatments used Topical including cleansers and moisturizer Oral medications:

Treatments used Topical including cleansers and moisturizer Oral medications: Discipline: Dermatology Extended Topic: Acne & Rosacea : Onset: Location: Face Chest Back Menses if female: Regular Irregular PCOS Treatments used Topical including cleansers and moisturizer Oral medications:

More information

OCCG SERVICE SPECIFICATION (2017/18)

OCCG SERVICE SPECIFICATION (2017/18) OCCG SERVICE SPECIFICATION (2017/18) Primary Care Service for Skin Cancers: Dermatology Shared Care Monitoring for Melanoma, Lichen Sclerosus and Squamos Cell Carcinoma 1. Background For patients who have

More information

My ear won t stop hurting!

My ear won t stop hurting! This month: 1. My ear won t stop hurting! 5. Cortisone Cream Didn t Help! 2. What are these red bumps? 6. Can my girlfriend get it? 3. Why won t this rash leave? 7. My wife noticed it! 4. What s the cause

More information

A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ. Övermark, Meri.

A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ. Övermark, Meri. https://helda.helsinki.fi A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ Övermark, Meri 2016 Övermark, M, Koskenmies, S & Pitkanen, S 2016, ' A Retrospective Study of Treatment of

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 12, 2012 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various

More information

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden Skin Cancer Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts 13.10.16 Skin Cancer Melanoma mole cancer - is a true cancer which can metastasize and kill Non Melanoma skin cancer

More information

The future of Skin Cancer Treatment

The future of Skin Cancer Treatment The future of Skin Cancer Treatment What is ZaicaDerm? Fully formulated cream that delivers Tea Tree Oil in a transdermal format Using proprietary technology, ZaicaDerm, delivers 10% Tea Tree Oil below

More information

Disorders of the vulva

Disorders of the vulva Vulval lesions Disorders of the vulva Terminology standardised by the International Society for the Study of Vulvovaginal Disease(ISSVD) Classification 1.Nonneoplastic epithelial disorders of vulva Lichen

More information

Chapter 8 Skin Disorders and Diseases

Chapter 8 Skin Disorders and Diseases Chapter 8 Skin Disorders and Diseases Attitude is more important than the past, than education, than money, than circumstances, than what people do or say. It is more important than appearance, giftedness,

More information

Basal cell carcinoma 5/28/2011

Basal cell carcinoma 5/28/2011 Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers

More information

Review of Cutaneous Malignancies

Review of Cutaneous Malignancies Review of Cutaneous Malignancies Tanya Nino, MD Department of Dermatology Did You Know? More than 3.5 million skin cancers are diagnosed in the US annually Melanoma incidence rates have been increasing

More information

Cutaneous reactions to targeted therapies. Stavonnie Patterson, MD, FAAD Northwestern University Feinberg School of Medicine March 6, 2017

Cutaneous reactions to targeted therapies. Stavonnie Patterson, MD, FAAD Northwestern University Feinberg School of Medicine March 6, 2017 Cutaneous reactions to targeted therapies Stavonnie Patterson, MD, FAAD Northwestern University Feinberg School of Medicine March 6, 2017 Disclosures I have no relevant disclosures Papulopustular Eruption

More information

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses.

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses. Dermatology in Primary Care Identifying Benign and Malignant Skin Lesions Christy Quire Baker, APRN, FNP-BC, DCNP Dermatology Certified Nurse Practitioner No Disclosures Common Benign Lesions Seborrheic

More information

Non-melanoma Skin Cancer

Non-melanoma Skin Cancer Non-melanoma Skin Cancer Understanding your diagnosis 1 888 939-3333 cancer.ca Non-melanoma Skin Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid.

More information

Squamous Cell Skin Cancer

Squamous Cell Skin Cancer Please complete our online survey at NCCN GUIDELINES FOR PATIENTS NCCN.org/patients/survey 2019 Squamous Cell Skin Cancer Presented with support from: Available online at NCCN.org/patients Ü Squamous Cell

More information

Eyelid basal cell carcinoma Patient information

Eyelid basal cell carcinoma Patient information Eyelid basal cell carcinoma Patient information Your procedure relates to the face, eyelids, orbit or tear drainage system that together are treated by specialist surgeons in the field of oculoplastic

More information

Mohs. Micrographic Surgery. For Treating Skin Cancer

Mohs. Micrographic Surgery. For Treating Skin Cancer Mohs Micrographic Surgery For Treating Skin Cancer Skin Cancer Basics Skin cancer is common. Over the past three decades, more people have had skin cancer than all other cancers combined. Each year in

More information

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis Leon H. Kircik M.D. Clinical Associate Professor of Dermatology Indiana University School of Medicine Mount Sinai Medical Center, New York, NY Physicians Skin Care, PLLC Louisville, KY 1 ICD 10 Codes L82.1

More information

VACAVILLE DERMATOLOGY

VACAVILLE DERMATOLOGY Connecting the Dots on those Spots NANDAN V. KAMATH, M.D. VACAVILLE DERMATOLOGY Sources All of the photos were taken with permission from the Dermnet NZ website - Dermnet New Zealand after communicating

More information

Lid Lesions: Relax or Refer

Lid Lesions: Relax or Refer Lid Lesions: Relax or Refer Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu Agenda Benign vs. Malignant lesions Benign Eyelid

More information

Dr A Anzarut, MSc, CIP, MD, FRCSC

Dr A Anzarut, MSc, CIP, MD, FRCSC Dr A Anzarut, MSc, CIP, MD, FRCSC Plastic and Cosmetic Surgery ASSH Fellowship trained hand surgeon 201 2763 Beverly Street, Duncan, British Columbia Tel: (250) 597 2064 Fax: (250) 597-1297 PATIENT INFORMATION

More information

ISPUB.COM. A Case of Actinic Lichen Planus. K Choi, H Kim, H Kim, Y Park INTRODUCTION CASE REPORT

ISPUB.COM. A Case of Actinic Lichen Planus. K Choi, H Kim, H Kim, Y Park INTRODUCTION CASE REPORT ISPUB.COM The Internet Journal of Dermatology Volume 8 Number K Choi, H Kim, H Kim, Y Park Citation K Choi, H Kim, H Kim, Y Park.. The Internet Journal of Dermatology. 2009 Volume 8 Number. Abstract The

More information

MOHS MICROGRAPHIC SURGERY

MOHS MICROGRAPHIC SURGERY MOHS MICROGRAPHIC SURGERY The Treatment of Skin Cancer What is Mohs Micrographic Surgery? Mohs Micrographic surgery is a specialized, highly effective technique used to treat skin cancer. The goal of Mohs

More information

CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge

CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge Yuri T. Jadotte, MD, a Navér A. Sarkissian, MD, PhD, b,c Helchem Kadire, MD, c and W. Clark Lambert, MD, PhD b,c

More information

Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery

Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery Dermoscopy in the evaluation and treatment of hair loss Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Antonella Tosti, MD

More information

Malignant Melanoma Early Stage. A guide for patients

Malignant Melanoma Early Stage. A guide for patients This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University

More information

EXCESSIVE SUN EXPOSURE A DANGER FACTOR FOR THE SKIN

EXCESSIVE SUN EXPOSURE A DANGER FACTOR FOR THE SKIN EXCESSIVE SUN EXPOSURE A DANGER FACTOR FOR THE SKIN When the weather warms up, we all like to get more sunshine. While better weather can make us feel brighter, we must also be aware of the dangers as

More information

Frequently Asked Questions

Frequently Asked Questions Ida Orengo, M.D. Mohsin Mir, M.D. Department of Dermatology 1977 Butler Boulevard, Suite E6.200 Houston, TX 77030 (713) 798-6925 / (713) 798-6624 telephone (713) 798-5535 fax Frequently Asked Questions

More information

Nonmelanoma skin cancers

Nonmelanoma skin cancers Skin cancer Philip Clarke Nonmelanoma skin cancers Treatment options Background Australia has one of the highest skin cancer rates in the world. Early detection and treatment of skin cancer is vital to

More information

Dermatology Procedure Coding

Dermatology Procedure Coding Dermatology Procedure Coding Anatomy Two layers that make up human skin Epidermis most superficial layer Composed of four to five layers called stratum Anyone remember the mnemonic? Thickness varies based

More information

Prescribing Information

Prescribing Information Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division

More information

Fire and Ice. An introduction to electrosurgery and cryosurgery of the skin. CU SOM Rural Track Mark Deutchman MD

Fire and Ice. An introduction to electrosurgery and cryosurgery of the skin. CU SOM Rural Track Mark Deutchman MD Fire and Ice An introduction to electrosurgery and cryosurgery of the skin CU SOM Rural Track Mark Deutchman MD Electrosurgery of the skin Uses: Cutting Coagulation during cold knife surgery or electrosurgery

More information

Developing the next generation of dermatology products to treat serious skin diseases

Developing the next generation of dermatology products to treat serious skin diseases Developing the next generation of dermatology products to treat serious skin diseases Tom Wiggans Chairman and Chief Executive Officer www.peplin.com Forward Looking Statements This presentation contains

More information

Technicians & Nurses Program

Technicians & Nurses Program ASCRS ASOA Symposium & Congress Technicians & Nurses Program May 6-10, 2016 New Orleans Evaluation and Treatment of Eyelid Malignancies Richard C. Allen MD PhD FACS Professor Section of Ophthalmology Dept.

More information

NHS. Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions)

NHS. Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) NHS National Institute for Health and Clinical Excellence Issue date: February 2006 Photodynamic therapy for non-melanoma skin (including premalignant and primary non-metastatic skin lesions) Understanding

More information

Skin disorders. Basal cell carcinoma December 2009 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig ...

Skin disorders. Basal cell carcinoma December 2009 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig ... December 29 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig.................................................. ABSTRACT INTRODUCTION: (BCC) is the most common form of skin cancer, predominantly affecting

More information

Tips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic

Tips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic Tips on Evaluation and Diagnosis of Scarring Alopecias Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic Disclosures I do not have any relevant relationships with industry Investigator:

More information